Redx Pharma (REDX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 7.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 32.38
  • 52 Week Low: 4.00
  • Currency: UK Pounds
  • Shares Issued: 126.48m
  • Volume: 23,348
  • Market Cap: 9.49m
  • RiskGrade: 342
  • Beta: 0.27

Redx Pharma Overview

Redx Pharma is in the pharma and biotech sector and is currently trading at 7.50p per share. In the last year Redx Pharma's share price has ranged from 4.00p to 32.38p.

1 Day Chart (23-10-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 6.5% n/a
ROCE 8.9%  
Latest F'cast
P/E 5.4 n/a
PEG n/a n/a
Pr/Revenue 0.3 n/a
Pr/Book 0.7  
Latest F'cast
Revenue n/a -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Redx Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-14 n/a (4.26) (7.60)p n/a n/a n/a n/a 0.0%
30-Sep-15 n/a (8.82) (14.10)p n/a n/a n/a n/a 0.0%
30-Sep-16 n/a (15.41) (19.80)p n/a n/a n/a n/a 0.0%
30-Sep-17 30.47 1.65 1.40p 23.1 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Redx Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-18 n/a (8.65) (6.50)p n/a n/a n/a n/a 0.0%
30-Sep-19 n/a (13.33) (8.80)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Redx Pharma Company Announcements

Redx Pharma Announces Way Forward For RXC004 04-Sep-2018 07:00 RNS
Directorate Update and Grant of Options 04-Jun-2018 07:00 RNS
Interim Results 30-May-2018 07:00 RNS

Latest Redx Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Redx Pharma Market Data

Currency UK Pounds
Share Price 7.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 32.38
52 Week Low 4.00
Volume 23,348
Shares Issued 126.48m
Market Cap 9.49m
Beta 0.27
RiskGrade 342

Redx Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.37% above the market average76.37% above the market average76.37% above the market average76.37% above the market average76.37% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Price Trend
49.22% below the market average49.22% below the market average49.22% below the market average49.22% below the market average49.22% below the market average
54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average
Income Not Available
Growth Not Available

Redx Pharma Dividends

No dividends found

Trades for 23-Oct-2018

Time Volume / Share Price
15:55 5,834 @ 7.30p
12:11 8,514 @ 7.30p
11:50 9,000 @ 7.30p

Redx Pharma Key Personnel

CFO Dominic Jackson

Top of Page